(Q73739705)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Paul Gregorevic

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

S A Cuffe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D R Plant

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Neuromuscular Disorders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

260-268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

Is there a future for gene therapy?

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Metabolic and structural effects of insulin-like growth factor-I and high-protein diet on dystrophic hamster skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

The potential role of insulin-like growth factors in skeletal muscle regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Association of IGF-I and IGF-II with myofiber regeneration in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Dystrophy and myogenesis in mdx diaphragm muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Phenotype of dystrophinopathy in old mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Myosin isoforms in hindlimb muscles of normal and dystrophic (ReJ129 dy/dy) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Contractile properties of skeletal muscles from young, adult and aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

CONTRACTION ENHANCEMENT IN SKELETAL MUSCLES OF NORMAL AND DYSTROPHIC MICE

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Contractile properties of developing mouse dystrophic muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Active state of normal and dystrophic mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Increase in oxidative capacity of muscle fibers in dystrophic mice and correlation with overactivity in these fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Quantitative measurement of muscle strength in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

The effects of endurance exercise on dystrophic mdx mice. II. Contractile properties of skinned muscle fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Histopathology of hereditary, progressive muscular dystrophy in inbred strain 129 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Role of IGF-I in muscular atrophy of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Postnatal profiles of myogenic regulatory factors and the receptors of TGF-beta 2, LIF and IGF-I in the gastrocnemius and rectus femoris muscles of dy mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Connective tissue proliferation and growth factors in animal models of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

Potential for growth factor treatment of muscle disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900192-9

7 January 2021

10.1016/S0960-8966(00)00192-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297941%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference